4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-24-002812
Options or other derivatives
- Head of Pharm Ops and Tech acquired 856 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Murphy Nicole · Head of Pharm Ops and Tech
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-29 | Grant or award : show line 1 in the form Performance Stock Unit | +856 | 856 | D |
Loading xslF345X05/form4.xml…